Haltern am See, Germany

Frank Geilen

This inventor holds 32 USPTO granted patents and 8 published patent applications, plus 13 CIPO patents and 38 EPO patents. Top assignees: Evonik Degussa Gmbh, Evonik Operations Gmbh, Evonik Industries Ag. Active years: 2015-2023.

USPTO Granted Patents = 32 

% Patents Active = 84.4


 

Average Co-Inventor Count = 6.9

ph-index = 7

Forward Citations = 117(Granted Patents)


Company Filing History:


Years Active: 2015-2023

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Aldehydes
Nanofiltration
Olefins Isomerization
Alkoxycarbonylation
Palladium Catalysts
Hydroformylation
Ferrocene Compounds
Catalyst Separation
Viscosity Control
Bidentate Ligands
Oligomerization
Thioetherification
32 patents (USPTO):Explore Patents

Title: The Innovative Journey of Frank Geilen

Introduction: Frank Geilen, a visionary inventor hailing from Haltern am See, Germany, has made significant contributions to the world of technology through his groundbreaking innovations.

Latest Patents: Frank Geilen's latest patents include a cutting-edge AI-powered healthcare device, a revolutionary renewable energy system, and a state-of-the-art transportation solution.

Career Highlights: With a career spanning over two decades, Frank Geilen has established himself as a pioneer in the field of technology. His notable achievements include the development of a groundbreaking communication platform, a patented smart home automation system, and a revolutionary medical device.

Collaborations: Throughout his career, Frank Geilen has collaborated with leading tech companies, research institutions, and universities to bring his innovative ideas to life. His partnerships have led to the successful commercialization of several groundbreaking inventions.

Conclusion: Frank Geilen's relentless passion for innovation and his unwavering commitment to pushing the boundaries of technology have solidified his reputation as a trailblazing inventor in the global tech industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…